Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2017
At a glance
- Drugs Sodium fytate (Primary)
- Indications Calciphylaxis; Cardiovascular disorders
- Focus Therapeutic Use
- Sponsors Laboratoris Sanifit
- 22 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 22 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Sep 2017.
- 20 Oct 2016 According to Sanifit media release, first data from this study is expected in Q2 of 2017.